share_log

Arbutus Biopharma | SC 13D: Statement of acquisition of beneficial ownership by individuals-Whitefort Capital Master Fund, LP(6.8%),Whitefort Capital GP, LLC(6.8%), etc.

SEC announcement ·  May 9 08:02
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more